Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CJJD China Jo-Jo Drugstores		$1.64	$1.29 ▼ $3.08	$10.05M	-0.13	12,988 shs	5,774 shs
CVS CVS Health	$65.30 -0.9%	$66.49	$43.56 ▼ $71.45	$82.33B	0.57	11.81 million shs	5.02 million shs
MDVL MedAvail		$3.31	$1.31 ▼ $20.89	$2.91M	0.76	261,432 shs	245,100 shs
WBA Walgreens Boots Alliance	$11.01 -0.2%	$10.95	$8.08 ▼ $18.83	$9.52B	0.67	20.97 million shs	6.35 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CJJD China Jo-Jo Drugstores	0.00%	0.00%	0.00%	-14.45%	-47.93%
CVS CVS Health	+0.43%	-1.97%	-1.02%	+20.39%	-2.80%
MDVL MedAvail	0.00%	0.00%	0.00%	0.00%	0.00%
WBA Walgreens Boots Alliance	+0.36%	+1.29%	-0.81%	-7.08%	-38.07%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CJJD China Jo-Jo Drugstores	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CVS CVS Health	4.9873 of 5 stars	3.5	5.0	3.3	3.9	4.0	3.3	3.1
MDVL MedAvail	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WBA Walgreens Boots Alliance	2.8286 of 5 stars	0.9	4.0	2.5	2.3	2.7	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CJJD China Jo-Jo Drugstores	0.00	N/A	N/A	N/A
CVS CVS Health	2.91	Moderate Buy	$71.94	10.17% Upside
MDVL MedAvail	0.00	N/A	N/A	N/A
WBA Walgreens Boots Alliance	1.83	Reduce	$10.59	-3.81% Downside

Current Analyst Ratings Breakdown

Latest MDVL, CJJD, CVS, and WBA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/15/2025	CVS CVS Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
4/15/2025	CVS CVS Health	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$51.00 ➝ $71.00
4/11/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$76.00 ➝ $82.00
4/9/2025	CVS CVS Health	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$70.00 ➝ $76.00
3/21/2025	CVS CVS Health	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$72.00 ➝ $74.00
2/28/2025	WBA Walgreens Boots Alliance	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$11.00 ➝ $9.00
2/24/2025	WBA Walgreens Boots Alliance	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
2/18/2025	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$77.00
2/18/2025	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$80.00 ➝ $81.00
2/13/2025	CVS CVS Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$68.00 ➝ $73.00
2/13/2025	CVS CVS Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$60.00 ➝ $76.00

(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CJJD China Jo-Jo Drugstores	$147.13M	0.00	N/A	N/A	N/A	NaN
CVS CVS Health	$372.81B	0.22	$9.12 per share	7.16	$60.06 per share	1.09
MDVL MedAvail	$43.33M	0.00	N/A	N/A	$13.01 per share	0.00
WBA Walgreens Boots Alliance	$151.95B	0.06	$6.02 per share	1.83	$13.91 per share	0.79

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CJJD China Jo-Jo Drugstores	-$4.23M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
CVS CVS Health	$4.61B	$3.66	17.84	9.65	0.98	1.24%	9.11%	2.71%	5/1/2025 (Estimated)
MDVL MedAvail	-$47.62M	-$28.72	N/A	N/A	N/A	-192.97%	-218.10%	-103.45%	N/A
WBA Walgreens Boots Alliance	-$8.64B	-$6.69	N/A	7.54	1.31	-5.87%	17.61%	2.89%	6/26/2025 (Estimated)

Latest MDVL, CJJD, CVS, and WBA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2025	Q1 2025	CVS CVS Health	$1.62	N/A	N/A	N/A	$93.07 billion	N/A
4/8/2025	Q2 2025	WBA Walgreens Boots Alliance	$0.53	$0.63	+$0.10	-$3.30	$37.90 billion	$38.59 billion
2/12/2025	Q4 2024	CVS CVS Health	$0.89	$1.19	+$0.30	$1.30	$96.90 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CJJD China Jo-Jo Drugstores	N/A	N/A	N/A	N/A	N/A
CVS CVS Health	$2.66	4.07%	+9.97%	72.68%	N/A
MDVL MedAvail	N/A	N/A	N/A	N/A	N/A
WBA Walgreens Boots Alliance	$1.00	9.08%	-19.12%	N/A	N/A

Latest MDVL, CJJD, CVS, and WBA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/20/2025	CVS CVS Health	quarterly	$0.6650	3.89%	4/22/2025	4/22/2025	5/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CJJD China Jo-Jo Drugstores	N/A	N/A	N/A
CVS CVS Health	0.80	0.81	0.60
MDVL MedAvail	N/A	N/A	N/A
WBA Walgreens Boots Alliance	0.68	0.64	0.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CJJD China Jo-Jo Drugstores	45.26%
CVS CVS Health	80.66%
MDVL MedAvail	N/A
WBA Walgreens Boots Alliance	58.59%

Insider Ownership

Company	Insider Ownership
CJJD China Jo-Jo Drugstores	24.80%
CVS CVS Health	1.22%
MDVL MedAvail	1.50%
WBA Walgreens Boots Alliance	17.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CJJD China Jo-Jo Drugstores	980	6.65 million	5.00 million	Not Optionable
CVS CVS Health	300,000	1.26 billion	1.26 billion	Optionable
MDVL MedAvail	279	1.61 million	1.59 million	No Data
WBA Walgreens Boots Alliance	325,000	864.74 million	712.93 million	Optionable

MDVL, CJJD, CVS, and WBA Headlines

Recent News About These Companies

Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025 ...

April 25 at 5:43 PM | gurufocus.com

Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025

April 25 at 5:42 PM | gurufocus.com

Walgreens Boots Alliance Initiates Securitization Facility

April 25 at 8:12 AM | tipranks.com

Fayez Sarofim & Co Trims Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

April 24 at 6:33 AM | marketbeat.com

Ossiam Has $1.08 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

April 24 at 5:35 AM | marketbeat.com

Capital World Investors Sells 1,675,764 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

April 24 at 5:24 AM | marketbeat.com

CANADA LIFE ASSURANCE Co Trims Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

April 24 at 4:42 AM | marketbeat.com

Walgreens reaches $300m deal over opioid prescriptions claims

April 23 at 5:52 PM | finance.yahoo.com

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline | WBA Stock News

April 23 at 1:49 PM | gurufocus.com

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline

April 23 at 1:48 PM | gurufocus.com

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline

April 23 at 6:45 AM | investing.com

Jim Cramer on Walgreens (WBA): “Clock’s Ticking on That One”

April 22 at 8:29 PM | insidermonkey.com

Walgreens Stock (WBA) Rises on Reports of $350 Million Opioid Settlement

April 22 at 2:43 PM | tipranks.com

Walgreens (WBA) Agrees to $300 Million Settlement over Opioid Claims

April 22 at 12:08 PM | theglobeandmail.com

Walgreens to pay $300M to settle with Department of Justice over opioid allegations

April 22 at 7:06 AM | chicagotribune.com

Walgreens agrees to $300M opioid settlement over improper prescriptions

April 22 at 7:06 AM | msn.com

Walgreens to pay $300 million in US opioid settlement

April 22 at 7:06 AM | msn.com

Walgreens to pay up to $350M for filling illegal opioid prescriptions, Justice Department says

April 22 at 5:36 AM | foxbusiness.com

Walgreens To Pay Up To $350 Mln For Opioid Settlement

April 22 at 4:39 AM | rttnews.com

Jump Financial LLC Purchases 157,689 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

April 22 at 4:17 AM | marketbeat.com

Walgreens to pay up to $350 million in U.S. opioid settlement

April 21, 2025 | financialpost.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Are Tariffs Threatening Disney’s Comeback Story?
By Jea Yu | April 9, 2025
View Are Tariffs Threatening Disney’s Comeback Story?
Signs of a more buyer-friendly housing market emerge for the spring homebuying season
By The Associated Press | April 6, 2025
View Signs of a more buyer-friendly housing market emerge for the spring homebuying season
4 Healthcare Stocks With Massive Gains—and More to Come
By Sarah Horvath | March 29, 2025
View 4 Healthcare Stocks With Massive Gains—and More to Come
Top 3 S&P 500 Winners in a Losing Market
By Ryan Hasson | April 9, 2025
View Top 3 S&P 500 Winners in a Losing Market
Walgreens Comeback? Private Equity Circling for a Buyout
By Gabriel Osorio-Mazilli | April 13, 2025
View Walgreens Comeback? Private Equity Circling for a Buyout

MDVL, CJJD, CVS, and WBA Company Descriptions

China Jo-Jo Drugstores NASDAQ:CJJD

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates retail pharmacies under the Jiuzhou Grand Pharmacy name. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

CVS Health NYSE:CVS

$65.30 -0.62 (-0.94%)

Closing price 03:59 PM Eastern

Extended Trading

$65.44 +0.14 (+0.21%)

As of 07:25 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

MedAvail NASDAQ:MDVL

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Walgreens Boots Alliance NASDAQ:WBA

$11.01 -0.02 (-0.18%)

Closing price 04:00 PM Eastern

Extended Trading

$11.02 +0.01 (+0.05%)

As of 07:24 PM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time